Channel Sponsor - Valuation

Sponsored by VMG Health | | (214) 369-4888

AmSurg Makes Concurrent Public Offerings of 10M in Stock to Finance $2.35B Sheridan Deal

Share on Facebook
AmSurg has announced public offerings of 8.5 million shares of its common stock at $45 per share and 1.5 million shares of its 5.25 percent mandatory convertible preferred stock, a total of 10 million shares, according to a Street Insider report.

The convertible stock, set to covert to common stock in July 2017, is being sold at $100 per share, according to a Nashville Post report.

AmSurg intends to use the proceeds from the two public offerings, as well as cash and debt financing, to bank roll its $2.35 billion acquisition of Sheridan Healthcare.

As of Tuesday afternoon, AmSurg shares were down 2 percent to $48.96, but year-to-date the shares are up nearly 7 percent, according to the Nashville Post report.

More Articles on Transactions and Valuation Issues:
14 ASC Industry Acquisition Agreements in 2014
How to Increase the Value of Your ASC
Medical Facilities Corporation Announces June Dividend

© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


New From Becker's ASC Review

National Bank Financial raises MFC's price target to C$16.50

Read Now